Providers should do a good history check and talk with the patient face-to-face, either virtually or in person, says Rhonda Bonilla, NP, a board-certified nurse practitioner at Sculpt, a wellness center in Pasco, Washington, that uses GLP-1s to aid weight loss
Chan HP, et al
Written by Anton Helman, June 2017 Euglycemic DKA can occur in any diabetic and has been reported in the literature since the 1970s, but there has recently been a rise in incidence of euglycemic DKA associated with sodium-glucose co-transporter 2 inhibitors (SGLT-2 inhibitors, or the zins) such as Canagliflozin, Dapagliflozin and Empagliflozin
It offers less side effects & more weight loss than first generation and GLP-1 medications only
Hu, X., Zhang, Y., Xue, Y., Zhang, Z., & Wang, J